Last reviewed · How we verify
NVP-1805-R1and NVP-1805-R2 — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
NVP-1805-R1and NVP-1805-R2 (NVP-1805-R1and NVP-1805-R2) — NVP Healthcare.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| NVP-1805-R1and NVP-1805-R2 TARGET | NVP-1805-R1and NVP-1805-R2 | NVP Healthcare | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- NVP-1805-R1and NVP-1805-R2 CI watch — RSS
- NVP-1805-R1and NVP-1805-R2 CI watch — Atom
- NVP-1805-R1and NVP-1805-R2 CI watch — JSON
- NVP-1805-R1and NVP-1805-R2 alone — RSS
Cite this brief
Drug Landscape (2026). NVP-1805-R1and NVP-1805-R2 — Competitive Intelligence Brief. https://druglandscape.com/ci/nvp-1805-r1and-nvp-1805-r2. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab